Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
CGDV vs XLV: how they differ
CGDV and XLV hold 10% of their weight in the same names, and XLV returned more over the year.
Capital Group Dividend Value ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, CGDV and XLV hold 10% of their money in the same securities at the same weight.
| Holding | CGDV | XLV |
|---|---|---|
| Eli Lilly & Co | 3.15% | 16.56% |
| UnitedHealth Group Inc | 2.03% | 6.59% |
| AbbVie Inc | 1.35% | 7.76% |
| Medtronic PLC | 1.07% | 1.75% |
| Vertex Pharmaceuticals Inc | 0.80% | 2.20% |
| Amgen Inc | 0.79% | 3.41% |
| Abbott Laboratories | 0.76% | 2.76% |
| Only in CGDV | Only in XLV |
|---|---|
| Microsoft Corp 5.81% | Johnson & Johnson 10.67% |
| NVIDIA Corp 5.66% | Merck & Co Inc 5.54% |
| Broadcom Inc 5.16% | Thermo Fisher Scientific Inc 3.25% |
| Alphabet Inc 3.60% | Gilead Sciences Inc 2.74% |
| Meta Platforms Inc 3.33% | Intuitive Surgical Inc 2.46% |
| Applied Materials Inc 3.12% | Pfizer Inc 2.40% |
| General Electric Co 3.08% | CVS Health Corp 2.30% |
| Cisco Systems Inc 3.02% | Danaher Corp 2.10% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
| CGDV Capital Group Dividend Value ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Capital | State Street |
| What it is | Dividend Value | Health care |
| Total return, 1 year | +18.7% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +1.2 pts | +2.9 pts |
| Expense ratio | 0.33% | 0.08% |
| Already in the S&P 500 | 91.0% | 100.0% |
| Holdings | 53 | 59 |
CGDV in plain words
CGDV is an index equity fund tracking the Dividend Value. Over the year to Sep 11, 2026 it returned +18.7% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.33% a year. By its holdings filed for May 31, 2026, 91% of the fund by weight is stocks the S&P 500 also holds, across 53 positions, with the top ten at 38.8%. It sat 4.0% below its high of Aug 13, 2026 on Sep 11, 2026.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, CGDV or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, CGDV returned +18.7% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, CGDV or XLV?
- CGDV charges 0.33% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do CGDV and XLV overlap with the S&P 500?
- By their latest filed holdings, 91% of CGDV and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 10% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, CGDV against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/CGDV-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources